Collaboration versus outsourcing: the need to think outside the box.

摘要: As has been widely reviewed elsewhere, the pharmaceutical industry is experiencing an 'innovation deficit' as evidenced by decline in new chemical entity output. This decline, compounded increased costs and regulatory requirements highlights need to significantly revise strategic options across drug-discovery spectrum. Within such revision(s), much of focus on outsourcing reduce, or at least contain, costs, but if underlying predominance 'closed collaborations' not challenged allow better use combined knowledge and, thus, move towards a more genuine collaborative process then 'numbers only' approach will bring medium-to-long-term survival. There are many problems confront evolving sustainable strategies, real think differently exists should be cultivated. article reviews current collaboration strategies provide perspective how great sharing could help process.